Stock Events

Stock Events

Beyond Air 

$0.71
66
-$0-0.64% Thursday 20:00

Statistics

Day High
0.72
Day Low
0.65
52W High
5.84
52W Low
0.65
Volume
184,484
Avg. Volume
7,547,496
Mkt Cap
5.68M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-2.44
-1.68
-0.91
-0.15
Expected EPS
-0.5375
Actual EPS
N/A

Financials

-1,258.43%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
7.41MRevenue
-93.25MNet Income

Analyst Ratings

$10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XAIR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Inovio Pharmaceuticals
INO
Mkt Cap124.89M
Inovio Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines, competing in the broader biotech space with Beyond Air's focus on nitric oxide therapies.
Moderna
MRNA
Mkt Cap10.61B
Moderna, Inc. specializes in drug discovery and drug development based on messenger RNA, competing in the innovative treatment space similar to Beyond Air.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical Inc. develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, a direct competitor in the biotech and treatments market.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals Incorporated is known for creating new possibilities in medicine to cure diseases and improve people's lives, competing with Beyond Air in the lung disease treatment space.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, competing in the same broad biopharmaceutical field as Beyond Air.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, and commercializes medicines for the treatment of serious medical conditions, directly competing with Beyond Air's therapeutic solutions.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions, competing in the biotech industry alongside Beyond Air.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics based on RNA interference, competing in the innovative treatment market similar to Beyond Air.
Biogen
BIIB
Mkt Cap22.63B
Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurological diseases to patients worldwide, competing in the broader biopharmaceutical field with Beyond Air.

About

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Show more...
CEO
Mr. Steven Adam Lisi
Employees
107
Country
US
ISIN
US08862L2025

Listings

F
DE
48L0.F
BOATS
BOATS
XAIR.BOATS
XNAS
US
XAIR

0 Comments

Share your thoughts

FAQ

What is Beyond Air stock price today?▼
The current price of XAIR is $0.71 USD — it has decreased by -0.64% in the past 24 hours. Watch Beyond Air stock price performance more closely on the chart.
What is Beyond Air stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Beyond Air stocks are traded under the ticker XAIR.
Is Beyond Air stock price growing?▼
XAIR stock has fallen by -1.76% compared to the previous week, the month change is a -14.36% fall, over the last year Beyond Air has showed a -85.31% decrease.
What is Beyond Air market cap?▼
Today Beyond Air has the market capitalization of 5.68M
When is the next Beyond Air earnings date?▼
Beyond Air is going to release the next earnings report on June 29, 2026.
What were Beyond Air earnings last quarter?▼
XAIR earnings for the last quarter are -0.85 USD per share, whereas the estimation was -0.75 USD resulting in a -13.26% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Beyond Air revenue for the last year?▼
Beyond Air revenue for the last year amounts to 7.41M USD.
What is Beyond Air net income for the last year?▼
XAIR net income for the last year is -93.25M USD.
How many employees does Beyond Air have?▼
As of April 05, 2026, the company has 107 employees.
In which sector is Beyond Air located?▼
Beyond Air operates in the Health Care sector.
When did Beyond Air complete a stock split?▼
The last stock split for Beyond Air was on July 14, 2025 with a ratio of 1:20.
Where is Beyond Air headquartered?▼
Beyond Air is headquartered in Garden City, US.